Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

NCT00379574 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large-Cell, Diffuse
Lymphoma, B-Cell

Interventions

DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisolone
DRUG: Lenograstim

Sponsor

Asan Medical Center

Collaborators

[object Object]